From the FDA: Janssen withdraws Hismanal

Artikel in diesem Heft

1. Letters to the Editor
2. Response: The dilemma of publishing OMT studies in JAOA
3. Remember the DO difference
4. Guide to available resources
5. News
6. From the FDA: New labeling and use changes for Rezulin
7. From the FDA: HIV home tests can be inaccurate
8. From the FDA: Janssen withdraws Hismanal
9. From the NCI: Childhood cancer deaths decline
10. From the NIH: Groups unite on recommended diet
11. From the CDC: Black women more likely to die giving birth
12. From the CDC: CDC adds three diseases to notifiable list
13. From the CDC: Teens underestimate HIV risk
14. From the NIDA: Addicts with other problems need lengthier treatment
15. From the NBDRC: Drop in blood donations could mean national shortage
16. From the FTC: 'Operation Cure.All' targets Internet health fraud
17. From the DHHS: New policy to ensure donated livers research the sickest patients
18. Letters to the Editor
19. The dilemma of publishing OMT studies in JAOA
20. Book Reviews
21. The Collected Papers of Viola M. Frymann, DO: Legacy of Osteopathy to Children
22. Editorial Comments
23. Editorial comments
24. News
25. From the FDA: New glucose monitoring system approved
26. Editorials
27. As uniquely trained holistic caregivers, DOs have duty to overweight patients
28. Original Contribution
29. Osteopathic family physicians' attitudes, knowledge, and self-reported practices regarding obesity
30. Clinical Practice
31. Childhood obesity
32. Medical Education
33. Training osteopathic geriatric academicians: Impact of a model geriatric residency program
34. CME Quiz
35. CME QUIZ